Lv11
60 积分 2025-09-02 加入
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
9分钟前
待确认
The Dynamic Alternation of Local and Systemic Tumor Immune Microenvironment During Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial
1小时前
已完结
Immunotherapy plus chemoradiotherapy in cervical cancer management
1小时前
已完结
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
1天前
已完结
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
10天前
已完结
Immunotherapy plus chemoradiotherapy in cervical cancer management
12天前
已完结
A phase I clinical trial of radiation therapy, durvalumab and tremelimumab in recurrent gynecologic cancer
20天前
已完结
Cervical cancer
1个月前
已完结
Induction chemotherapy followed by chemoradiotherapy for locally advanced cervical cancer: A systematic review and meta-analysis
1个月前
已完结
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
